Supply Chain Research

U.S. imports of anticonvulsant drugs increased 37% on a year earlier in the third quarter, Panjiva data shows. Generic versions of Johnson & Johnson’s Topamax led the way, with a 206% increase perhaps following approval for use in adolescent migraines. Around 80% of generic anticonvulsants exported to the U.S. come from India, with Aurobindo and Cipla the leaders. The landscape for generic drug exporters may change though – the FDA approved 3D printing of a generic version of UCB’s Keppra by Aprecia in March.